Prof. Gerhard Opelz 1944–2026. The Genius Behind the Collaborative Transplant Study (CTS)
Clinical Transplantation · 2026-11 · 40 (11)
DOI: 10.1111/ctr.70738 ↗At a glance
Journal article in Clinical Transplantation, published online on 2026-11-05. Written by Robert Peter Gale.
Abstract (original language)
I am a consultant to Antengene Biotech LLC, Ascentage Pharma and Shenzen Target Rx, Inc; Medical Director, FFF Enterprises Inc.; A speaker for Janssen Pharma, Suzhou Lianyihui Network Technology and Hengrui Pharma; Board of Directors: Russian Foundation for Cancer Research Support; and Scientific Advisory Board: StemRad Ltd. Data sharing not applicable to this article as no datasets were generated or analyzed during the current study.
Cite
APA
Gale, R. P. (2026). Prof. Gerhard Opelz 1944–2026. The Genius Behind the Collaborative Transplant Study (CTS). Clinical Transplantation, 40(11). https://doi.org/10.1111/ctr.70738
Vancouver
Gale RP. Prof. Gerhard Opelz 1944–2026. The Genius Behind the Collaborative Transplant Study (CTS). Clinical Transplantation. 2026;40(11). doi:10.1111/ctr.70738
BibTeX
@article{Gale2026,
author = {Gale, Robert Peter},
title = {Prof. Gerhard Opelz 1944–2026. The Genius Behind the Collaborative Transplant Study (CTS)},
journal = {Clinical Transplantation},
year = {2026},
volume = {40},
number = {11},
doi = {10.1111/ctr.70738}
}
EUVIMED